Webinar for stakeholder engagement on the new draft guideline on general considerations for patient preference studies (ICH E22)
EventHumanMedicinesScientific guidelines
Date
Location
The new draft ICH E22 guideline addresses general considerations for patient preference studies (PPS) to inform drug development and regulatory submissions. It aims to harmonise patient preference studies using a globally agreed framework.
This webinar presents the draft E22 guideline, seeking to encourage stakeholder feedback to incorporate their insights and experiences into the development of ICH E22.
The objectives of the webinar are to:
• describe the draft E22 guideline and facilitate timely stakeholder engagement;
• encourage stakeholder feedback during the public consultation;
• support the development of training materials.